Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
Rakon (RAK) / FY22

NPAT up 244.8% but cash conversion fell to 55.6% on inventory build

Record earnings were undercut by a $19.6m inventory build and capex more than doubling, cutting FCF/NPAT conversion from 164.5% to 60.6%.

Technology / Electronics

RAK revenue trajectory

Revenue context before the current result.

↗
Loading chart...
HY26 was $54.2m, versus $41.7m in HY25.

RAK EBITDA margin

EBITDA margin across covered periods.

↗
Loading chart...
HY26 was 6.6%, versus -37.9% in HY25.

RAK operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
HY26 was $6.4m, versus $8.3m in HY25.

RAK working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
  • HY24 RAK: Outside range high operating working-capital movement. $33.8m; 3-period range $-18.7m to $28.4m. Operating working-capital movement: NZ$33.8m, above normal range; 2/3 prior periods had builds averaging NZ$26.2m, and 1 had releases averaging NZ$-18.7m.
  • HY25 RAK: Outside range low operating working-capital movement. $-18.7m; 3-period range $24m to $33.8m. Operating working-capital movement: NZ$-18.7m, below normal range; 3/3 prior periods had builds averaging NZ$28.7m, and none had a working-capital release.
Operating working-capital movement: NZ$-18.7m, below normal range; 3/3 prior periods had builds averaging NZ$28.7m, and none had a working-capital release.
Release date
26 May 2022
Published
22 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

FY22 vs FY21

Revenue

$172m

+34.1% ↑ vs $128.3m

Net profit after tax

$33.1m

+244.8% ↑ vs $9.6m

Net cash inflow from operating activities

$30.2m

+50.7% ↑ vs $20.1m

Declared dividend per share

0.0c

— vs —

Operating profit

$41.4m

+265.9% ↑ vs $11.3m

Profit before tax

$41.9m

+274.1% ↑ vs $11.2m

Cash and cash equivalents

$39.2m

+160.3% ↑ vs $15.1m

Total assets

$199.9m

+29.5% ↑ vs $154.4m

What changed

Revenue grew 34.1% to $172.0m and profit before tax grew 274.1% to $41.9m, lifting NPAT 244.8% to $33.1m

The headline is a step-change in profitability, but the cash quality behind it weakened: operating cash flow rose only 50.7% to $30.2m, so OCF/EBITDA fell from 85.4% to 55.6% and FCF/NPAT conversion fell from 164.5% to 60.6%.

The drag came from working capital and capex. Inventories rose 52% ($19.6m) to $57.3m and inventory days extended from 107 to 122, while capex more than doubled to $10.2m (5.9% of revenue, up from 3.3%). Receivable days improved from 89 to 70.

Cash on hand rose to $39.2m against $16.0m of borrowings, leaving Rakon in a $23.2m net-cash position with equity of $135.2m.

What matters

Cash conversion deteriorated even as profits surged

OCF/EBITDA dropped roughly 30 percentage points and free cash flow ($20.1m pre-lease) covered only 60.6% of NPAT, against 164.5% in FY21. This matters because the gap between reported earnings growth and cash generation is now wide enough that the underlying economic improvement is materially smaller than the NPAT print suggests.

Inventory absorbed most of the cash gap. A $19.6m inventory build with inventory days extending 14 days is consistent with protective stocking through component shortages, but it carries obsolescence and write-down risk if demand cools. Trade receivables tightened (debtor days fell 19), so the working-capital pressure is concentrated on the inventory side, not the customer side.

Tax normalisation distorts the NPAT optic. The effective tax rate moved from –13.7% in FY21 (a tax benefit) to 21.0% in FY22, so PBT growth of 274.1% is the cleaner read on operating performance versus NPAT growth of 244.8%. Both are strong, but the 29.3pp gap between them is mechanical, not a deterioration.

Expectations

Rakon's HY22 release confirmed an Underlying EBITDA guidance range of $44–49m for FY22; the full-year result implies Underlying EBITDA of $54.4m per the announcement, comfortably ahead of that range

So this result delivered against, and beat, the only stated quantitative target.

No FY23 guidance, forward order book, or revenue target was disclosed in the supplied materials, and the second-half profile shows H1 carried 57.2% of NPAT and only 14.9% of operating cash flow — meaning H2 was the cash-recovery half, not the earnings half. Without a forward-work or guidance anchor, FY23 trajectory is not assessable from this release.

Quality of result

The earnings result is real but the cash result is softer than it looks

PBT growth of 274.1% reflects genuine operating leverage on a 34.1% revenue lift, and ROE expanded from 9.3% to 24.5%, indicating the higher profits are flowing through to capital efficiency. New segment disclosure shows Telecommunications at 50.2% of revenue (44% gross margin) with higher-margin Space & Defence (69.4%) and Positioning (56%) supporting mix.

The quality concerns are timing- and balance-sheet-driven rather than accounting-driven:

  • Inventory build of $19.6m drove most of the working-capital outflow and is the single largest reason cash conversion fell.
  • Capex stepped up 142.5% to $10.2m, raising capex intensity to 5.9% of revenue and depressing free cash flow.
  • The 80%+ of cash flow that arrived in H2 (HY22 OCF was just $4.5m) suggests the working-capital pattern was lumpy within the year.

A new dividend policy was announced but no dividend was declared for FY22, so capital-return follow-through cannot be tested yet.

Unresolved

Open questions

Is the $19.6m inventory build a deliberate hedge against component shortages, and how much carries obsolescence risk if customer demand softens in FY23?
What is the FY23 capex trajectory, and is the 5.9% capex/revenue level a new run rate or a one-off capacity step-up?
What does the new dividend policy translate to in cents-per-share terms, and when will the first declaration sit?
How much forward order coverage or customer commitment underpins the inventory position?
Will the effective tax rate stabilise near 21%, or does the FY21 benefit reflect timing items that could reverse again?

This briefing cannot assess underlying demand visibility, customer concentration, or the durability of segment gross margins without forward-order, customer-mix, and segment-trend disclosures that are not in the supplied materials.

Chat

Ask about RAK FY22

Ask follow-up questions about Rakon's FY22 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about RAK FY22

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Rakon's FY22 result.

Is the $19.6m inventory build a deliberate hedge against component shortages, and how much carries obsolescence risk if customer demand softens in FY23?Why does "Cash conversion deteriorated even as profits surged" matter?How strong was the cash and earnings quality in FY22?What should I watch next for RAK after FY22?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Rakon Annual Report 2022

FY22 / financial report↗

Rakon FY22 Financial Results & Business Update presentation

FY22 / results presentation↗

Rakon FY22 Results Announcement

FY22 / results announcement↗

Rakon FY22 Results Announcement Commentary

FY22 / results release↗

Prior comparable period

Rakon Annual Report FY2021

FY21 / financial report↗

Rakon FY2021 Annual Report and Review Announcement

FY21 / results release↗

Interim context

Rakon 1H22 Interim Report

HY22 / financial report↗

Rakon 1H22 Results Announcement

HY22 / results announcement↗

Rakon 1H22 Results Announcement

HY22 / results release↗

Related insights

Cross-company views selected from the metrics in this briefing.

Cash conversion quality

This result converted 55.6% of EBITDA to operating cash flow, -29.8pp versus the prior comparable period.

→

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 29.3pp, with a distortion flag in the result.

→

Working-capital pressure

Inventory days were 122 days, +14 days versus the prior comparable period.

→

Revenue growth context

Revenue growth was 34.1% for this reporting period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when RAK publishes next

Get the next Rakon briefing and related NZX reporting-season updates by email.